TUSC3 and cancer: To investigate whether TUSC3 protein expression level and other clinicopathological factors are associated with clinical outcome of PC patients, univariate and multivariate Cox proportional hazard models for CSS (Cancer Specific Survival) and RFS (Recurrence Free Survival) were calculated.